Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review

Background: Coronavirus disease-2019 (COVID-19) is a novel infectious disease, which presents with various clinical manifestations. There is growing evidence of an association between COVID-19 infection and autoimmune diseases. The aim of this case report was to demonstrate the association of COVID-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shirin Assar, Mehran Pournazari, Parviz Soufivand, Dena Mohamadzadeh
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Autoimmunity COVID-19 Systemic lupus erythematosus SARS-CoV-2 Case report Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/a7bd5e7dad8647cf9e02305b670f5fd2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a7bd5e7dad8647cf9e02305b670f5fd2
record_format	dspace
spelling	oai:doaj.org-article:a7bd5e7dad8647cf9e02305b670f5fd22021-11-12T04:27:03ZSystemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review1110-116410.1016/j.ejr.2021.08.013https://doaj.org/article/a7bd5e7dad8647cf9e02305b670f5fd22022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1110116421000934https://doaj.org/toc/1110-1164Background: Coronavirus disease-2019 (COVID-19) is a novel infectious disease, which presents with various clinical manifestations. There is growing evidence of an association between COVID-19 infection and autoimmune diseases. The aim of this case report was to demonstrate the association of COVID-19 infection and the development of systemic lupus erythematosus (SLE). Case presentation: A 38 year old Iranian woman presented with progressive icterus, pleuritic chest pain, palpitation, dyspnea, photosensitivity and arthralgia 18-days after COVID-19 symptoms proved by a positive polymerized chain reaction (PCR). The chest and abdomen computerized tomography (CT) scan showed pericardial and pleural effusion and enlarged liver and abdominal lymph nodes. Antinuclear antibody (ANA), anti-double stranded deoxyribonucleic acid (anti-ds DNA) antibody and perinuclear anti-neutrophil cytoplasmic antibody (P-ANCA) were positive. She was diagnosed as SLE and was successfully treated with prednisolone 30 mg daily, hydroxychloroquine 200 mg daily and azathioprine 150 mg daily and she remarkably improved. Repeated anti-ds DNA antibody was positive. Due to nausea and abdominal discomfort, azathioprine was discontinued and replaced with mycophenolate mofetil 1500 mg daily. In the article, similar cases were presented; the mean interval between COVID symptoms and SLE presentations was 24.86 days. Pulmonary and renal involvements were the most common presentations of SLE triggered by COVID-19. The most frequently reported autoantibody was ANA Conclusion: It is necessary to be aware of the development of lupus disease in COVID-19 infected patients, because prompt diagnosis and treatment is very important to improve their outcome.Shirin AssarMehran PournazariParviz SoufivandDena MohamadzadehElsevierarticleAutoimmunityCOVID-19Systemic lupus erythematosusSARS-CoV-2Case reportImmunologic diseases. AllergyRC581-607ENEgyptian Rheumatologist, Vol 44, Iss 2, Pp 145-149 (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Autoimmunity COVID-19 Systemic lupus erythematosus SARS-CoV-2 Case report Immunologic diseases. Allergy RC581-607
spellingShingle	Autoimmunity COVID-19 Systemic lupus erythematosus SARS-CoV-2 Case report Immunologic diseases. Allergy RC581-607 Shirin Assar Mehran Pournazari Parviz Soufivand Dena Mohamadzadeh Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
description	Background: Coronavirus disease-2019 (COVID-19) is a novel infectious disease, which presents with various clinical manifestations. There is growing evidence of an association between COVID-19 infection and autoimmune diseases. The aim of this case report was to demonstrate the association of COVID-19 infection and the development of systemic lupus erythematosus (SLE). Case presentation: A 38 year old Iranian woman presented with progressive icterus, pleuritic chest pain, palpitation, dyspnea, photosensitivity and arthralgia 18-days after COVID-19 symptoms proved by a positive polymerized chain reaction (PCR). The chest and abdomen computerized tomography (CT) scan showed pericardial and pleural effusion and enlarged liver and abdominal lymph nodes. Antinuclear antibody (ANA), anti-double stranded deoxyribonucleic acid (anti-ds DNA) antibody and perinuclear anti-neutrophil cytoplasmic antibody (P-ANCA) were positive. She was diagnosed as SLE and was successfully treated with prednisolone 30 mg daily, hydroxychloroquine 200 mg daily and azathioprine 150 mg daily and she remarkably improved. Repeated anti-ds DNA antibody was positive. Due to nausea and abdominal discomfort, azathioprine was discontinued and replaced with mycophenolate mofetil 1500 mg daily. In the article, similar cases were presented; the mean interval between COVID symptoms and SLE presentations was 24.86 days. Pulmonary and renal involvements were the most common presentations of SLE triggered by COVID-19. The most frequently reported autoantibody was ANA Conclusion: It is necessary to be aware of the development of lupus disease in COVID-19 infected patients, because prompt diagnosis and treatment is very important to improve their outcome.
format	article
author	Shirin Assar Mehran Pournazari Parviz Soufivand Dena Mohamadzadeh
author_facet	Shirin Assar Mehran Pournazari Parviz Soufivand Dena Mohamadzadeh
author_sort	Shirin Assar
title	Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
title_short	Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
title_full	Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
title_fullStr	Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
title_full_unstemmed	Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
title_sort	systemic lupus erythematosus after coronavirus disease-2019 (covid-19) infection: case-based review
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/a7bd5e7dad8647cf9e02305b670f5fd2
work_keys_str_mv	AT shirinassar systemiclupuserythematosusaftercoronavirusdisease2019covid19infectioncasebasedreview AT mehranpournazari systemiclupuserythematosusaftercoronavirusdisease2019covid19infectioncasebasedreview AT parvizsoufivand systemiclupuserythematosusaftercoronavirusdisease2019covid19infectioncasebasedreview AT denamohamadzadeh systemiclupuserythematosusaftercoronavirusdisease2019covid19infectioncasebasedreview
_version_	1718431308231737344

Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review

Ejemplares similares